18F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study
Fig 3
68y old patient with prostate cancer Gleason score 7 treated 1 year ago by radical prostatectomy.
Serum PSA level at the time of FCH PET/CT 2.4ng/mL; On FCH PET/CT equivocal focus in the right prostate loge and left pulmonary lesion evocative of malignancy. Scheduled androgen deprivation therapy was replaced by watchful waiting and 4 months later, by radiation therapy on prostate loge. Pulmonary lesion was resected and histology confirmed poorly differentiated large cell lung cancer with visceral pleural invasion.